Federal Appeals Court Clears Medtronic in Major Patent Case, Overturns Jury’s $106 Million Ruling
WASHINGTON — A federal appeals court has ruled in favor of Medtronic Plc in a lengthy patent lawsuit involving the company and Colibri Heart Valve LLC, reversing a jury’s decision that charged Medtronic with inducing patent infringement concerning artificial heart valves. The case centered on Colibri’s U.S. patent No. 8,900,294, which describes a technique for partially deploying and recapturing an artificial heart valve during implantation. This method allows surgeons to reposition the valve if its initial placement is not optimal, effectively providing a “do-over” during surgery. Colibri accused Medtronic of promoting this technique through its … Read more